1 Introduction
More than 20% of stroke cases are caused by cardiac embolism attributable to atrial fibrillation (AF) (1). Compared to strokes of other etiologies, AF-related ischemic stroke (AF-stroke) is associated with greater severity and a higher risk of disability and mortality (2). This may be due to large infarct volumes resulting from the abrupt occlusion of blood flow by a clot originating in the heart, often without sufficient time for collateral circulation to compensate (3). Numerous studies have shown that AF-stroke is associated with a lower likelihood of early neurological improvement (ENI) (2, 4, 5). Nevertheless, ENI can still occur in a subset of patients with AF-stroke and is associated with favorable functional outcomes (6).
Several factors have been linked to ENI, including successful recanalization, collateral status, and smaller infarct core size (6–8). Additionally, the endothelium plays multiple roles in stroke pathophysiology and recovery by regulating vascular tone, maintaining blood–brain barrier (BBB) integrity, modulating inflammatory responses, and influencing thrombotic and fibrinolytic balance (9–11). Patients who have experienced acute ischemic stroke (AIS) with impaired FMD are associated with early neurological deterioration and poor long-term outcome (12). Furthermore, endothelial function is associated with the development of AF and AF-stroke by promoting atrial remodeling, thrombogenesis, and hemodynamic alterations (13, 14). However, whether endothelial function influences the capacity for early neurological recovery in patients with AF-stroke remains unclear.
Brachial artery flow-mediated dilation (FMD), assessed using high-resolution ultrasonography, is a widely used tool to evaluate endothelial function (15). In this study, we aimed to identify the factors associated with ENI in patients with AF-stroke, with a particular focus on the role of endothelial function as measured by FMD.
More at link.
Sung Hee Ahn3
Yuzheng Lai1